Heavy menstrual flow: current and future trends in management.
article
OA: green
CC0
⤵ 1 in-corpus citation
AI-generated summary
This review discusses current and emerging medical and surgical management strategies for menorrhagia, considering varying patient age and treatment expectations.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Menorrhagia accounts for a large number of secondary care referrals in the West. Women of different ages have different expectations from the treatment offered to them. Young women of reproductive age often demand treatment that simultaneously reduces bleeding, preserves fertility, and has very few side effects, whereas older women who ultimately wish to keep their reproductive organs may have reason to avoid hormonal manipulation. This article discusses possible management options and introduces a hierarchical approach to the management of menorrhagia based on the medical therapies and surgical procedures currently available. We explore the medical therapies for menorrhagia, which include hormone-modifying drug therapies and the new combined oral contraceptive pill. We also review novel fibroid surgical therapies and the latest surgical procedures, such as laparoscopic bilateral uterine artery occlusion, transvaginal Doppler-guided vascular clamp, and laparoscopic and intrauterine ultrasound-guided radiofrequency ablation.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (65)
- A Benefit-Risk Assessment of Medical Treatment for Uterine Leiomyomas via openalex
- Benefits and Risks of Pharmacological Agents Used for the Treatment of Menorrhagia via openalex
- Can symptomatology help in the diagnosis of endometriosis? Findings from a national case–control study—Part 1 via openalex
- Dienogest via openalex
- Efficacy of mefenamic acid in patients with a complaint of menorrhagia. via openalex
- Laparoscopic Ultrasound-Guided Radiofrequency Ablation of Uterine Fibroids via openalex
- Management of Cyclical Menorrhagia with Prostaglandin Synthetase Inhibitor via openalex
- Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding via openalex
- Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding via openalex
- Randomized Trial of 2 Hormonal and 2 Prostaglandin‐inhibiting Agents in Women with a Complaint of Menorrhagia via openalex
- Review of the safety, efficacy and patient acceptability of the combined dienogest/estradiol valerate contraceptive pill via openalex
- The effects of 1-month administration of asoprisnil (J867), a selective progesterone receptor modulator, in healthy premenopausal women via openalex
- W2001004078 via openalex
- W2007614802 via openalex
- W2011004184 via openalex
- W2014636341 via openalex
- W2015401367 via openalex
- W2021738675 via openalex
- W2023261682 via openalex
- W2030285251 via openalex
- W2031785143 via openalex
- W2032960682 via openalex
- W2034897568 via openalex
- W2036662832 via openalex
- W2041637524 via openalex
- W2043006565 via openalex
- W2046804851 via openalex
- W2049555849 via openalex
- W2069642788 via openalex
- W2080066358 via openalex
- W2086126831 via openalex
- W2086483733 via openalex
- W2091692603 via openalex
- W2094437002 via openalex
- W2095354180 via openalex
- W2101146672 via openalex
- W2102218899 via openalex
- W2118407369 via openalex
- W2120835813 via openalex
- W2121683982 via openalex
- W2125475755 via openalex
- W2127978899 via openalex
- W2132061576 via openalex
- W2135057319 via openalex
- W2135562886 via openalex
- W2140405854 via openalex
- W2145951812 via openalex
- W2154693051 via openalex
- W2157547283 via openalex
- W2158879960 via openalex
- W2166833540 via openalex
- W2418241203 via openalex
- W4255816668 via openalex
- doi:10.1017/s0266462300008679 via openalex
- W63062164 via openalex
- W207870397 via openalex
- W1512767282 via openalex
- W1583068547 via openalex
- W1624155247 via openalex
- W1870591762 via openalex
- W1899079722 via openalex
- W1971178436 via openalex
- W1973974063 via openalex
- W1977908865 via openalex
- W1979137115 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK